Tevogen Bio announced steps toward proprietary T Cell therapy for development of bivalent vaccine for COVID-19 and influenza
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
On Jul. 15, 2020, Tevogen Bio announced its intention to evaluate its proprietary antigen-specific T cell technology as…
On Jul. 15, 2020, four Einstein and Montefiore research teams received pilot funding from Einsteinメs Office of the…
On Jul. 15, 2020, AXIM Biotechnologies announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of…
On Jul. 15, 2020, A new Cleveland Clinic study identified genetic factors that may influence susceptibility to COVID-19….
On Jul. 15, 2020, Atossa Therapeutics announced successful results from in vitro testing of AT-301, Atossa’s proprietary COVID-19…
On Jul. 14, 2020, the WHO and UNICEF warned of an alarming decline in the number of children…
On Jul. 15, 2020, seventy-five countries submitted expressions of interest to protect their populations and those of other…
On Jul. 15, 2020, bioMerieux announced that the BIOFIRE Respiratory Panel 2.1 plus (RP2.1plus) was CE marked. The…
On Jul. 14, 2020, Akebia Therapeutics announced the initiation of an investigator-sponsored study evaluating the use of vadadustat,…
On Jul. 14, 2020, an investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus…
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
On Jul. 14, 2020, in an editorial published in the Journal of the American Medical Association (JAMA), the…
On Jul. 14, 2020, researchers at the The University of Hong Kong (HKUMed) collaborated with researchers at the…
On Jul. 14, 2020, Shanghai Fosun Pharmaceutical announced it had received the acceptance notice of clinical trial application…
On Jul. 14, 2020, Rigel Pharmaceuticals announced the initiation of an investigator-sponsored tria being conducted by Imperial College…
On Jul. 14, 2020, Dynavax Technologies announced that the first participants have been dosed in the Phase 1…
On Jul. 14, 2020, Moderna announced the publication of an interim analysis of the open-label Phase 1 study…
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
On Jul. 13, 2020, Meridian Bioscience announced it had launched a high-sensitivity SARS-CoV-2 nucleocapsid antibody pair for the…
On Jul. 13, 2020, researchers from Virginia Tech and the NIH suggested that Bacille Calmette-Gu�rin (BCG), a tuberculosis…
On Jul. 13, 2020, 20 million masks were made available at more than 700 partner restaurant locations, including…
On Jul. 13, 2020, a team of researchers from Oxford University, the Rosalind Franklin Institute, Diamond Light Source…
On Jul. 13, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced the enrollment of adult patients for…
On Jul. 13, 2020, Innovation Pharma announced that, in parallel to previously reported manufacturing efforts, the Company had…
On Jul. 13, 2020, Altimmune announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate,…
On Jul. 13, 2020, Bellerophon Therapeutics announced that the first patient has initiated treatment in the Companyメs Phase…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesメ four investigational vaccine candidates from…
On Jul. 13, 2020, BioReference Laboratories, an OPKO Health company, announced that it would provide COVID-19 testing oversight…
On Jul. 13, 2020, Tonix Pharmaceuticals announced a new preclinical research and option agreement with Kansas State University…
On Jul. 12, 2020, Royal Philips announced an addition to its remote patient monitoring suite supporting at-risk populations…